Conversion from calcineurin inhibitor to belatacept-based maintenance immunosuppression in renal transplant recipients: A randomized phase 3b trial
Journal of the American Society of Nephrology | Nov 02, 2021
Most read this week
Journal of the American Society of Nephrology | Nov 02, 2021